Validation of a high-pressure liquid chromatography and fluorescence polarization immunoassay for the determination of methadone in canine plasma

Therapeutic Drug Monitoring

Volumn 27, Issue 3, 2005, Pages 389-392

  KuKanich, Butch ^a   Lascelles, B Duncan X ^a   Papich, Mark G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Concentration; Dog; FPIA; HPLC

Indexed keywords

METHADONE; OPIATE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; DOG; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; TABLET;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; MALE; METHADONE;

EID: 20044390943     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000158078.15459.90     Document Type: Article

References (11)

1. Chizh BA, Schlutz H, Scheede M, et al. The N-methyl-D-aspartate antagonistic and opioid components of d-methadone antinociception in the rat spinal cord. Neurosci Lett. 2000;296:117-120.
2. Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223:5-8.
3. Callahan RJ, Au JD, Paul M, et al. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects. Anesth Analg. 2004;98:653-659.
4. Codd EE, Shank RP, Schupsky JJ, et al. Scrotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274:1263-1270.
5. Dale O, Hoffer C, Sheffels P, et al. Disposition of nasal, intravenous, and oral methadone in healthy volunteers. Clin Pharmacol Ther. 2002;72:536-545.
6. Gourlay GK, Willis RJ, Wilson PR. Postoperative pain control with methadone: influence of supplementary methadone doses and blood concentration-response relationships. Anesthesiology. 1984;61:19-26.
7. Gourlay GK, Willis RJ, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology. 1986;64:322-327.
8. Shah VP, Midha KK, Dighe S, et al. Conference report: analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. Int J Pharm. 1992;82:1-7.
9. Garrett ER, Derendorf H, Martha AG. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs. J Pharm Sci. 1985;74:1203-1214.
10. Cheng YF, Neue UD, Woods LL. Novel high-performance liquid chromatographic and solid-phase extraction methods for quantitating methadone and its metabolite in spiked human urine. J Chromatogr B Biomed Sci Appl. 1999;729:19-31.
11. Kell MJ, Techman T. Rapid measurement of plasma methadone in a clinical setting using florescence polarization immunoassay. J Addict Dis. 1996;15:69-83.